MENU
+Compare
ARTH
Stock ticker: OTC
AS OF
Apr 14 closing price
Price
$0.20
Change
+$0.04 (+25.00%)
Capitalization
888.87K

ARTH Arch Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Arch Therapeutics Inc is a development-stage biotechnology company... Show more

Ad is loading...
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

ARTH is expected to report earnings to fall 20,100.00% to $2.00 per share on March 01

Arch Therapeutics, Inc. ARTH Stock Earnings Reports
Q4'22
Est.
$2.00
Q3'22
Est.
$-0.01
Q2'22
Beat
by $0.01
Q1'22
Beat
by $0.01
The last earnings report on November 30 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 2.20K shares outstanding, the current market capitalization sits at 888.87K.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
235 Walnut Street
Phone
+1 617 431-2313
Employees
8
Web
https://www.archtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MURRX22.450.22
+0.99%
MFS Utilities R2
VEXPX98.170.69
+0.71%
Vanguard Explorer Inv
TQVIX16.550.09
+0.55%
T. Rowe Price Integrated US LCV Eq I
FIDAX16.810.09
+0.54%
JHancock Financial Industries A
FAOFX13.85-0.05
-0.36%
Fidelity Advisor Series Growth Opps

ARTH and Stocks

Correlation & Price change

A.I.dvisor tells us that ARTH and EDSA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARTH and EDSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTH
1D Price
Change %
ARTH100%
N/A
EDSA - ARTH
21%
Poorly correlated
-3.41%
HRMY - ARTH
20%
Poorly correlated
+1.86%
BIVI - ARTH
13%
Poorly correlated
+6.00%
APLIF - ARTH
12%
Poorly correlated
+12.73%
BETRF - ARTH
5%
Poorly correlated
+25.49%
More